Alemtuzumab induction in deceased donor kidney transplantation

Transplantation

Volumn 84, Issue 7, 2007, Pages 821-828

  Huang, Edmund ^a   Cho, Yong W ^b   Hayashi, Rick ^a   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Institute of Transplantation Los Angeles   (United States)

Author keywords

Alemtuzumab; Campath; Deceased donor; Immunosuppression; Induction

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE RECEPTOR ANTAGONIST; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR BLOCKING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; CALCINEURIN; CANCER ANTIBODY; CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; AGED; CHEMISTRY; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CALCINEURIN; CYCLOSPORINE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; STEROIDS; TACROLIMUS;

EID: 38449093900     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000281942.97406.89     Document Type: Article

References (24)